APA

Conroy T., Wils J., Paillot B., Wagener D. J., Burghouts J. T., Fickers M. M., de Graeff A. & Lalisang F. M. (19940607). [Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]. : Bulletin du cancer.

Chicago

Conroy T, Wils J, Paillot B, Wagener D J, Burghouts J T, Fickers M M, de Graeff A and Lalisang F M. 19940607. [Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]. : Bulletin du cancer.

Harvard

Conroy T., Wils J., Paillot B., Wagener D. J., Burghouts J. T., Fickers M. M., de Graeff A. and Lalisang F. M. (19940607). [Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]. : Bulletin du cancer.

MLA

Conroy T, Wils J, Paillot B, Wagener D J, Burghouts J T, Fickers M M, de Graeff A and Lalisang F M. [Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]. : Bulletin du cancer. 19940607.